
Leonhard Held
Articles
-
Oct 29, 2024 |
onlinelibrary.wiley.com | Charlotte Micheloud |Leonhard Held
1 Introduction Replicability of scientific findings is the gold standard for assessing their credibility. Recent years have witnessed an increased interest in large-scale replication projects, aiming to reproduce the results found in an original study in one or several replication studies. Various empirical domains of science are involved in these replication efforts: psychology (Open Science Collaboration 2015), social sciences (Camerer et al. 2016), economics (Camerer et al.
-
Oct 23, 2024 |
onlinelibrary.wiley.com | Leonhard Held
REPLY Response to Nadarajah First published: 23 October 2024 No abstract is available for this article. References 1S. Nadarajah, “Letter to the Editors,” Statistics in Medicine 43, no. 26 (2024): 5043–5045. 2L. Held, “Beyond the Two-Trials Rule,” Statistics in Medicine 43, no. 26 (2024): 5023–5042. 3W. H. Press, S. A. Teukolsky, W. T. Vetterling, and B. P. Flannery, Numerical Recipes—The Art of Scientific Computing, 3rd ed. (Cambridge, UK: Cambridge University Press, 2007). 4L.
-
May 13, 2024 |
elifesciences.org | Samuel Pawel |Rachel Heyard |Charlotte Micheloud |Leonhard Held
eLife assessment This work provides a valuable contribution and assessment of what it means to replicate a null study finding, and what are the appropriate methods for doing so (apart from a rote p-value assessment).
-
Apr 10, 2024 |
dialnet.unirioja.es | Samuel Pawel |Frederik Aust |Leonhard Held |Eric-Jan Wagenmakers
Samuel Pawel[1];Frederik Aust[2];Leonhard Held[1];Eric-Jan Wagenmakers[2][1]University of Zurich[2]University of AmsterdamLocalización: Test: An Official Journal of the Spanish Society of Statistics and Operations Research, ISSN-e 1863-8260, ISSN 1133-0686, Vol. 33, Nº. 1, 2024, págs. 127-154Idioma: inglésTexto completo no disponible (Saber más ...)ResumenThe ongoing replication crisis in science has increased interest in the methodology of replication studies.
-
Apr 4, 2024 |
onlinelibrary.wiley.com | Leonhard Held
1 INTRODUCTION The two trials rule is a standard requirement by the FDA to demonstrate efficacy of drugs. It demands “at least two pivotal studies, each convincing on its own”1 before drug approval is granted and “reflects the need for substantiation of experimental results, which has often been referred to as the need for replication of the finding”. 2 The rule is usually implemented by requiring two independent studies to be significant at the standard (one-sided) α = 0 .
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →